Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOUND HAVING ANTI-CANCER EFFECT, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/090974
Kind Code:
A1
Abstract:
Provided are a compound having the structure of formula I and a preparation method therefor and the use for treating cancers. The compound of the present invention has an inhibitory effect on various cancer cells and can be biologically converted into an active drug Linifanib in vitro (in plasma) so as to inhibit the proliferation of tumour cells, especially hepatoma cells, at a lower dose.

Inventors:
GONG JOHN (CN)
LIN YIHUI (CN)
LI FENGQING (CN)
TANG FANGQIANG (CN)
Application Number:
PCT/CN2017/111649
Publication Date:
May 24, 2018
Filing Date:
November 17, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
3D MEDICINES LTD (CN)
International Classes:
A61K31/416; A61K31/423; A61K31/428; A61P35/00; A61P35/04
Domestic Patent References:
WO2014201127A22014-12-18
Other References:
WU, XIAOYUN ET AL.: "Molecular Docking and 3D-QSAR Study on 4-(1H-indazol-4-yl) Phenylamino and Aminopyrazolopyridine Urea Derivatives as Kinase Insert Domain Receptor (KDR) Inhibitors", J MOL MODEL, vol. 18, no. 3, 31 December 2012 (2012-12-31), pages 1207 - 1218, XP035018246, ISSN: 0948-5023
LU , XIAOYUN ET AL.: "Pharmacophore Guided 3D-QSAR CoMFA Analysis of Amino Substituted Nitrogen Heterocycle Ureas as KDR Inhibitors", QSAR COMB. SCI., vol. 28, no. 11-12, 31 December 2009 (2009-12-31), pages 1524 - 1536, XP055503034, ISSN: 1611-020X
J. CLIN. ONCOL., vol. 33, 2014, pages 172 - 179
See also references of EP 3542796A4
Attorney, Agent or Firm:
HYLANDS LAW FIRM (CN)
Download PDF: